Home
Scholarly Works
Greater BMD Gains with Denosumab Vs Risedronate in...
Conference

Greater BMD Gains with Denosumab Vs Risedronate in Glucocorticoid-Treated Subjects: Results from the Final 24-Month Analysis of a Randomized, Double-Blind, Double-Dummy Study

Authors

Saag K; Pannacciulli N; Geusens P; Adachi JD; Messina OD; Morales-Torres J; Emkey R; Butler PW; Yin X; Lems WF

Volume

70

Publisher

WILEY

Publication Date

September 1, 2018

Name of conference

Annual Meeting of the American-College-of-Rheumatology (ACR) and Association-for-Rheumatology-Health-Professionals (ARHP)

Conference place

IL, Chicago

Conference start date

October 19, 2018

Conference end date

October 24, 2018

Conference proceedings

ARTHRITIS & RHEUMATOLOGY

ISSN

2326-5191

Contact the Experts team